Table 1 Baseline characteristics of the study population.
Total (N = 73) | No OSA (N = 25) | OSA (N = 48) | p | |
---|---|---|---|---|
Age, years | 40.3 ± 10.9 | 34.4 ± 8.4 | 43.3 ± 10.9 | < 0.001 |
Male, N (%) | 17 (23.3) | 4 (16.0) | 13 (27.1) | 0.29 |
Diabetes, N (%) | 27 (37.0) | 8 (32.0) | 19 (39.6) | 0.52 |
BMI, kg/m2 | 45.4 ± 6.3 | 44.6 ± 5.5 | 45.9 ± 6.7 | 0.40 |
Weight, kg | 126.8 ± 19.4 | 122.6 ± 18.7 | 128.9 ± 19.6 | 0.19 |
Waist circumference, cm | 127.2 ± 13.0 | 122.0 ± 11.9 | 129.9 ± 12.8 | 0.01 |
SBP, mmHg | 133.9 ± 18.5 | 129.9 ± 12.8 | 136.0 ± 12.8 | 0.13 |
DBP, mmHg | 83.2 ± 11.2 | 81.9 ± 8.2 | 83.8 ± 12.5 | 0.45 |
Hemoglobin, g/dL | 13.6 ± 1.4 | 13.4 ± 1.2 | 13.7 ± 1.5 | 0.39 |
Serum glucose, mg/dL | 98.0 (92.0–112.0) | 96.0 (85.0–102.0) | 102.5 (93.5–122.5) | 0.004 |
HbA1c, % | 5.5 (5.2–5.9) | 5.3 (4.9–5.5) | 5.7 (5.3–6.0) | 0.002 |
Total cholesterol, mg/dL | 204.4 ± 48.4 | 209.1 ± 42.7 | 201.9 ± 51.4 | 0.56 |
HDL cholesterol, mg/dL | 44.9 ± 10.0 | 47.2 ± 10.2 | 43.8 ± 9.9 | 0.17 |
LDL cholesterol, mg/dL | 131.5 ± 34.0 | 142.4 ± 34.6 | 125.9 ± 32.7 | 0.05 |
Triglycerides, mg/dL | 136.0 (99.0–183.0) | 113.0 (100.0–165.0) | 142.5 (97.0–203.0) | 0.33 |
Uric acid, mg/dL | 5.8 ± 1.4 | 5.5 ± 1.4 | 5.9 ± 1.4 | 0.15 |
Total proteins, g/dL | 7.4 ± 0.5 | 7.4 ± 0.5 | 7.4 ± 0.5 | 0.56 |
Albumin, g/dL | 4.4 ± 0.3 | 4.5 ± 0.3 | 4.4 ± 0.3 | 0.37 |
eGFR, ml/min/1.73 m2 | 103.8 ± 15.3 | 109.2 ± 13.9 | 100.9 ± 15.4 | 0.03 |
CRP, mg/dL | 0.8 (0.5–1.1) | 0.7 (0.4–0.9) | 0.9 (0.6–1.2) | 0.09 |
Fat, Kg | 57.1 ± 11.5 | 54.9 ± 9.4 | 58.3 ± 12.4 | 0.23 |
Percent fat, % | 45.2 ± 5.1 | 44.9 ± 4.7 | 45.3 ± 5.4 | 0.46 |